For the last six years the Immunology Section of the EAACI has been organizing a meeting for young doctoral and postdoctoral scientists, who are active in allergy and clinical immunology research with the goal to increase the impact of basic immunology research on the fields of allergy and clinical immunology. The list of keynote speakers who have participated in the past include outstanding scientist such as: Ulrich von Andrian, Kim Bottomly, Richard Flavell, Raif Geha, Erwin Gelfand, Ron Germain, David Gray, Patrik Holt, Juha Kere, Jean-Pierre Kinet, Peter Krammer, Antonio Lanzavecchia, Markus Manz, Philippa Marrack, Fritz Melchers, Lorenzo Moretta, Antonius Rolink, Robert Seder, Dale Umetsu, Hermann Wagner. The first four of these meetings, three of which took place in Davos, have been a great success and coined the name EAACI-Davos meeting.



The 5th EAACI-GA²LEN Davos Meeting “Basic Immunology Research in Allergy and Asthma” took place again in Davos between the 1st and the 4th of February, 2007. The meeting was organized by the Immunology Section, this time together with the Asthma Section of the EAACI, and the Swiss Institute for Allergy and Asthma Research, with generous support from GA²LEN.


The meeting included 5 main symposia on innate immunity, adaptive immunity and regulation in allergic inflammation. Each symposium opened by a keynote lecture followed by presentations of participants as selected from their abstracts. The keynote speakers included: Fred Finkelman, Cincinnati, OH, Steven Galli, Stanford, CA; Barry Kay, London, UK; Kenneth Murphy, St. Louis, MO; Marsha Wills-Karp, Cincinnati, OH Federica Sallusto,Bellinzona,CH


As in previous years the meeting was open to 70 participants, who were selected based on the scientific quality of the submitted abstract. 25 abstracts were presented as oral presentations.


The goal of the meeting was to create an engaging scientific environment in which allergy and asthma related immunological concepts could be covered with ample time for discussions and young scientist would have the opportunity to directly interact with known capacities in the field.



Thilo Jakob
Chairman of the EAACI Immunology Section

Last updated 14 July 2009